(Q37768080)

22 August 2017

1 reference

title

Pathogenesis of diffuse large B cell lymphoma (English)

1 reference

22 August 2017

0 references

Wing John C Chan

1

1 reference

22 August 2017

29 June 2010

1 reference

International Journal of Hematology

22 August 2017

1 reference

22 August 2017

92

1 reference

22 August 2017

2

1 reference

22 August 2017

219-230

1 reference

https://scigraph.springernature.com/pub.10.1007/s12185-010-0602-0

22 August 2017

0 references

cites work

BCL2 translocation defines a unique tumor subset within the germinal center B-cell-like diffuse large B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1007%2FS12185-010-0602-0

G.O.D.'s Holy Grail: Discovery of the RAG Proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-010-0602-0

Essential role of MALT1 protease activity in activated B cell-like diffuse large B-cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-010-0602-0

Cutting edge: constitutive B cell receptor signaling is critical for basal growth of B lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-010-0602-0

RAG proteins shepherd double-strand breaks to a specific pathway, suppressing error-prone repair, but RAG nicking initiates homologous recombination.

21 January 2018

1 reference

12 December 2020

Differentiation stage-specific expression of microRNAs in B lymphocytes and diffuse large B-cell lymphomas

1 reference

12 December 2020

MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia

1 reference

12 December 2020

The tumor microenvironment and its role in promoting tumor growth

1 reference

12 December 2020

The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma.

1 reference

12 December 2020

Two levels of protection for the B cell genome during somatic hypermutation.

1 reference

12 December 2020

TNFAIP3/A20 functions as a novel tumor suppressor gene in several subtypes of non-Hodgkin lymphomas

1 reference

12 December 2020

Microarray reveals differences in both tumors and vascular specific gene expression in de novo CD5+ and CD5- diffuse large B-cell lymphomas

1 reference

12 December 2020

Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers

1 reference

12 December 2020

Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma

1 reference

12 December 2020

Oncogenic CARD11 mutations in human diffuse large B cell lymphoma

1 reference

12 December 2020

Inactivation of the PRDM1/BLIMP1 gene in diffuse large B cell lymphoma

1 reference

12 December 2020

Mutations in the DNA-binding codons of TP53, which are associated with decreased expression of TRAILreceptor-2, predict for poor survival in diffuse large B-cell lymphoma

1 reference

12 December 2020

The significance of TP53 in lymphoid malignancies: mutation prevalence, regulation, prognostic impact and potential as a therapeutic target

1 reference

12 December 2020

Gene expression profiling in lymphoma diagnosis and management

1 reference

12 December 2020

Prognostic significance of VEGF, VEGF receptors and microvessel density in diffuse large B cell lymphoma treated with anthracycline-based chemotherapy

1 reference

12 December 2020

A microRNA polycistron as a potential human oncogene

1 reference

12 December 2020

Association of p19(ARF) with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53.

1 reference

12 December 2020

Mechanisms of chromosomal rearrangement in the human genome

1 reference

12 December 2020

The biology of human lymphoid malignancies revealed by gene expression profiling.

1 reference

12 December 2020

Homozygous deletion of SOCS1 in primary mediastinal B-cell lymphoma detected by CGH to BAC microarrays

1 reference

12 December 2020

Mutations of the BCL6 proto-oncogene disrupt its negative autoregulation in diffuse large B-cell lymphoma.

1 reference

12 December 2020

The biochemistry of somatic hypermutation

1 reference

12 December 2020

De novo CD5+ diffuse large B-cell lymphoma: results of a detailed clinicopathological review in 120 patients

1 reference

12 December 2020

Mutational analysis of PRDM1 indicates a tumor-suppressor role in diffuse large B-cell lymphomas

1 reference

12 December 2020

Targeted disruption of the S1P2 sphingosine 1-phosphate receptor gene leads to diffuse large B-cell lymphoma formation

1 reference

12 December 2020

Widespread microRNA repression by Myc contributes to tumorigenesis

1 reference

12 December 2020

Loss of major histocompatibility class II expression in non-immune-privileged site diffuse large B-cell lymphoma is highly coordinated and not due to chromosomal deletions.

1 reference

12 December 2020

Stem cell factor promotes mast cell survival via inactivation of FOXO3a-mediated transcriptional induction and MEK-regulated phosphorylation of the proapoptotic protein Bim.

1 reference

12 December 2020

A signaling pathway mediating downregulation of BCL6 in germinal center B cells is blocked by BCL6 gene alterations in B cell lymphoma.

1 reference

12 December 2020

Inhibition of Syk with fostamatinib disodium has significant clinical activity in non-Hodgkin lymphoma and chronic lymphocytic leukemia

1 reference

12 December 2020

Diffuse large B-cell lymphoma subgroups have distinct genetic profiles that influence tumor biology and improve gene-expression-based survival prediction

1 reference

12 December 2020

Specific peptide interference reveals BCL6 transcriptional and oncogenic mechanisms in B-cell lymphoma cells.

1 reference

12 December 2020

Cellular and molecular bases of B-cell clonal expansions

1 reference

12 December 2020

Deregulated BCL6 expression recapitulates the pathogenesis of human diffuse large B cell lymphomas in mice

1 reference

12 December 2020

Roles for NBS1 in alternative nonhomologous end-joining of V(D)J recombination intermediates.

1 reference

12 December 2020

Structural profiles of TP53 gene mutations predict clinical outcome in diffuse large B-cell lymphoma: an international collaborative study.

1 reference

12 December 2020

Stromal gene signatures in large-B-cell lymphomas

1 reference

12 December 2020

FAS Death Domain Deletions and Cellular FADD-like Interleukin 1 Converting Enzyme Inhibitory Protein (Long) Overexpression: Alternative Mechanisms for Deregulating the Extrinsic Apoptotic Pathway in Diffuse Large B-Cell Lymphoma Subtypes

1 reference

12 December 2020

Maintenance of human germinal center B cells in vitro.

1 reference

12 December 2020

Mutations of multiple genes cause deregulation of NF-kappaB in diffuse large B-cell lymphoma.

1 reference

12 December 2020

Role of rel family genes in normal and malignant lymphoid cell growth

1 reference

12 December 2020

Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma

1 reference

12 December 2020

Immunosuppressive mechanisms in human tumors: why we still cannot cure cancer

1 reference

12 December 2020

Regulation and functions of Blimp-1 in T and B lymphocytes

1 reference

12 December 2020

Integrated biochemical and computational approach identifies BCL6 direct target genes controlling multiple pathways in normal germinal center B cells.

1 reference

12 December 2020

Cancer genome sequencing: a review

1 reference

12 December 2020

Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways

1 reference

12 December 2020

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

1 reference

12 December 2020

Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes

1 reference

12 December 2020

A purine scaffold Hsp90 inhibitor destabilizes BCL-6 and has specific antitumor activity in BCL-6-dependent B cell lymphomas

1 reference

12 December 2020

Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas

1 reference

12 December 2020

Alternative translocation breakpoint cluster region 5' to BCL-6 in B-cell non-Hodgkin's lymphoma

1 reference

12 December 2020

BCL6-mediated attenuation of DNA damage sensing triggers growth arrest and senescence through a p53-dependent pathway in a cell context-dependent manner.

1 reference

12 December 2020

Patterns of microRNA expression characterize stages of human B-cell differentiation.

1 reference

12 December 2020

Loss of major histocompatibility class II gene and protein expression in primary mediastinal large B-cell lymphoma is highly coordinated and related to poor patient survival

1 reference

12 December 2020

Regulation of cytokine receptor signaling by SOCS1.

1 reference

12 December 2020

A tiling resolution DNA microarray with complete coverage of the human genome

1 reference

12 December 2020

Next-generation DNA sequencing

1 reference

12 December 2020

microRNAs exhibit high frequency genomic alterations in human cancer

1 reference

12 December 2020

Cooperative signaling through the signal transducer and activator of transcription 3 and nuclear factor-{kappa}B pathways in subtypes of diffuse large B-cell lymphoma

1 reference

12 December 2020

Differential efficacy of bortezomib plus chemotherapy within molecular subtypes of diffuse large B-cell lymphoma

1 reference

12 December 2020

Molecular diagnosis of Burkitt's lymphoma

1 reference

12 December 2020

Analysis of chromosomal imbalances in de novo CD5-positive diffuse large-B-cell lymphoma detected by comparative genomic hybridization

1 reference

12 December 2020

miR-15 and miR-16 induce apoptosis by targeting BCL2

1 reference

12 December 2020

Germinal centres: role in B-cell physiology and malignancy

1 reference

12 December 2020

The centrality of RNA.

1 reference

12 December 2020

MicroRNAs: target recognition and regulatory functions

1 reference

12 December 2020

Clinicopathologic characteristics and treatment outcome of the addition of rituximab to chemotherapy for CD5-positive in comparison with CD5-negative diffuse large B-cell lymphoma

1 reference

12 December 2020

Conditional immortalization of human B cells by CD40 ligation

1 reference

12 December 2020

JAK signaling globally counteracts heterochromatic gene silencing

1 reference

12 December 2020

The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma

1 reference

12 December 2020

Recurrent mutations of the STAT6 DNA binding domain in primary mediastinal B-cell lymphoma.

1 reference

12 December 2020

SYK-dependent tonic B-cell receptor signaling is a rational treatment target in diffuse large B-cell lymphoma

1 reference

12 December 2020

MicroRNAs: regulators of gene expression and cell differentiation

1 reference

12 December 2020

Accumulation of miR-155 and BIC RNA in human B cell lymphomas

1 reference

12 December 2020

Aberrant immunoglobulin class switch recombination and switch translocations in activated B cell-like diffuse large B cell lymphoma

1 reference

12 December 2020

Distinctive patterns of BCL6 molecular alterations and their functional consequences in different subgroups of diffuse large B-cell lymphoma

1 reference

12 December 2020

Biallelic mutation of SOCS-1 impairs JAK2 degradation and sustains phospho-JAK2 action in the MedB-1 mediastinal lymphoma line

1 reference

12 December 2020

10.1007/S12185-010-0602-0

Identifiers

DOI

1 reference

22 August 2017

1 reference

PubMed ID

20582737